Cargando…
Cell Technologies in the Stress Urinary Incontinence Correction
The scientific literature of recent years contains a lot of data about using multipotent stromal cells (MSCs) for urinary incontinence correction. Despite this, the ideal treatment method for urinary incontinence has not yet been created. The cell therapy results in patients and experimental animals...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8869383/ https://www.ncbi.nlm.nih.gov/pubmed/35203518 http://dx.doi.org/10.3390/biomedicines10020309 |
_version_ | 1784656484706025472 |
---|---|
author | Maiborodin, Igor Yarin, Gennadiy Marchukov, Sergey Pichigina, Aleksandra Lapii, Galina Krasil’nikov, Sergey Senchukova, Svetlana Ryaguzov, Maxim Vilgelmi, Inna Bakarev, Maksim Maiborodina, Vitalina |
author_facet | Maiborodin, Igor Yarin, Gennadiy Marchukov, Sergey Pichigina, Aleksandra Lapii, Galina Krasil’nikov, Sergey Senchukova, Svetlana Ryaguzov, Maxim Vilgelmi, Inna Bakarev, Maksim Maiborodina, Vitalina |
author_sort | Maiborodin, Igor |
collection | PubMed |
description | The scientific literature of recent years contains a lot of data about using multipotent stromal cells (MSCs) for urinary incontinence correction. Despite this, the ideal treatment method for urinary incontinence has not yet been created. The cell therapy results in patients and experimental animals with incontinence have shown promising results, but the procedures require further optimization, and more research is needed to focus on the clinical phase. The MSC use appears to be a feasible, safe, and effective method of treatment for patients with urinary incontinence. However, the best mode for application of cell technology is still under study. Most clinical investigations have been performed on only a few patients and during rather short follow-up periods, which, together with an incomplete knowledge of the mechanisms of MSC action, does not make it possible for their widespread implementation. The technical details regarding the MSC application remain to be identified in more rigorous preclinical and clinical trials. |
format | Online Article Text |
id | pubmed-8869383 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-88693832022-02-25 Cell Technologies in the Stress Urinary Incontinence Correction Maiborodin, Igor Yarin, Gennadiy Marchukov, Sergey Pichigina, Aleksandra Lapii, Galina Krasil’nikov, Sergey Senchukova, Svetlana Ryaguzov, Maxim Vilgelmi, Inna Bakarev, Maksim Maiborodina, Vitalina Biomedicines Review The scientific literature of recent years contains a lot of data about using multipotent stromal cells (MSCs) for urinary incontinence correction. Despite this, the ideal treatment method for urinary incontinence has not yet been created. The cell therapy results in patients and experimental animals with incontinence have shown promising results, but the procedures require further optimization, and more research is needed to focus on the clinical phase. The MSC use appears to be a feasible, safe, and effective method of treatment for patients with urinary incontinence. However, the best mode for application of cell technology is still under study. Most clinical investigations have been performed on only a few patients and during rather short follow-up periods, which, together with an incomplete knowledge of the mechanisms of MSC action, does not make it possible for their widespread implementation. The technical details regarding the MSC application remain to be identified in more rigorous preclinical and clinical trials. MDPI 2022-01-28 /pmc/articles/PMC8869383/ /pubmed/35203518 http://dx.doi.org/10.3390/biomedicines10020309 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Maiborodin, Igor Yarin, Gennadiy Marchukov, Sergey Pichigina, Aleksandra Lapii, Galina Krasil’nikov, Sergey Senchukova, Svetlana Ryaguzov, Maxim Vilgelmi, Inna Bakarev, Maksim Maiborodina, Vitalina Cell Technologies in the Stress Urinary Incontinence Correction |
title | Cell Technologies in the Stress Urinary Incontinence Correction |
title_full | Cell Technologies in the Stress Urinary Incontinence Correction |
title_fullStr | Cell Technologies in the Stress Urinary Incontinence Correction |
title_full_unstemmed | Cell Technologies in the Stress Urinary Incontinence Correction |
title_short | Cell Technologies in the Stress Urinary Incontinence Correction |
title_sort | cell technologies in the stress urinary incontinence correction |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8869383/ https://www.ncbi.nlm.nih.gov/pubmed/35203518 http://dx.doi.org/10.3390/biomedicines10020309 |
work_keys_str_mv | AT maiborodinigor celltechnologiesinthestressurinaryincontinencecorrection AT yaringennadiy celltechnologiesinthestressurinaryincontinencecorrection AT marchukovsergey celltechnologiesinthestressurinaryincontinencecorrection AT pichiginaaleksandra celltechnologiesinthestressurinaryincontinencecorrection AT lapiigalina celltechnologiesinthestressurinaryincontinencecorrection AT krasilnikovsergey celltechnologiesinthestressurinaryincontinencecorrection AT senchukovasvetlana celltechnologiesinthestressurinaryincontinencecorrection AT ryaguzovmaxim celltechnologiesinthestressurinaryincontinencecorrection AT vilgelmiinna celltechnologiesinthestressurinaryincontinencecorrection AT bakarevmaksim celltechnologiesinthestressurinaryincontinencecorrection AT maiborodinavitalina celltechnologiesinthestressurinaryincontinencecorrection |